The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
Using Indirect Comparisons of Prospective, Randomized Trials to Make Therapeutic Decisions in Melanoma: Cross-Trial Comparisons as Surrogates for Proper Head-To-Head Studies? Clinical trials are ...
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
Patient Engagement With Clinicians and Family Members About Genetic Test Results Across Risk Groups in Women With Hereditary Cancer Susceptibility Cooperative group cancer clinical trials have long ...
Peeples Cancer Institute at Hamilton Medical Center has expanded access to the latest in cancer research for patients in north Georgia and the surrounding area by opening National Cancer Institute ...
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
Mark Ratain’s First Opinion piece of Feb. 4, 2025, implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exelixis to sponsor two Phase 3 studies of its ...
Represents first ever triplet combination using targeted radiotherapy as a backbone therapy in AML with initial clinical data expected in 2H:2025 Expansion into frontline setting greatly expands ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results